Target intelligence / Profile preview

PTPRK antisense RNA 1 (PTPRK-AS1)

Target: PTPRK-AS1
Molecular classification: Other (long non-coding RNA, lncRNA)

Overview

PTPRK antisense RNA 1 (PTPRK-AS1) is a long non-coding RNA that is transcribed antisense to the PTPRK gene[4]. There is currently no evidence that PTPRK-AS1 encodes a protein or functions as a receptor, enzyme, transporter, or other canonical drug target class. Its detailed biological functions and potential disease relevance have not been well described in available sources. There are no established aliases, biomarker roles, molecular targeting strategies, or therapeutic/toxicity concerns reported for this transcript at this time[4]. This lncRNA should not be confused with the protein-coding gene PTPRK (protein tyrosine phosphatase, receptor type Kappa), which is a receptor-type tyrosine phosphatase involved in cell signaling and cancer biology[1][2][7].

Beyond the preview

Go deeper on PTPRK antisense RNA 1 (PTPRK-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PTPRK antisense RNA 1 (PTPRK-AS1).

Explore the full profile